T2 Biosystems Inc EV / EBITDA
Was ist das EV / EBITDA von T2 Biosystems Inc?
EV / EBITDA von T2 Biosystems Inc ist N/A
Was ist die Definition von EV / EBITDA?
EV / EBITDA ist der Unternehmenswert geteilt durch das Einkommen vor Zinsen, Steuern, Abschreibungen und Amortisationen. Es ist ein Maß dafür, wie teuer eine Aktie ist und für Vergleiche zwischen Unternehmen häufiger gültig ist als das Preis-Gewinn-Verhältnis. Er misst den Preis (in Form des Unternehmenswerts), den ein Investor zu Gunsten des Cashflows des Unternehmens (in Form des EBITDA) bezahlt.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu T2 Biosystems Inc
Was macht T2 Biosystems Inc?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Unternehmen mit ev / ebitda ähnlich T2 Biosystems Inc
- Prime Intelligence Solutions hat EV / EBITDA von N/A
- K.B. Recycling Industries hat EV / EBITDA von N/A
- Forward Water Technologies hat EV / EBITDA von N/A
- Fjordland Exploration hat EV / EBITDA von N/A
- Aquarius AI hat EV / EBITDA von N/A
- Sipa Resources hat EV / EBITDA von N/A
- T2 Biosystems Inc hat EV / EBITDA von N/A
- RightCrowd hat EV / EBITDA von N/A
- China Strategic hat EV / EBITDA von N/A
- Deliveroo Plc hat EV / EBITDA von N/A
- Singulus Technologies AG hat EV / EBITDA von N/A
- Inventiva S.A hat EV / EBITDA von N/A
- Pascal Biosciences hat EV / EBITDA von N/A